Diane M Lester, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9485 Mentor Avenue, 101, Mentor, OH 44060 Phone: 440-205-5800 Fax: 440-205-5801 |
Barbara L Davis, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9485 Mentor Avenue, #101, Mentor, OH 44060 Phone: 440-205-5800 Fax: 440-205-5801 |
Simee I Malik, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9485 Mentor Avenue, #101, Mentor, OH 44060 Phone: 440-205-5800 Fax: 440-205-5801 |
Joy Ertel, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9000 Mentor Ave Ste 100, Mentor, OH 44060 Phone: 440-974-4411 Fax: 440-974-4173 |
Zhuo Tina Yang, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 7060 Wayside Dr, Mentor, OH 44060 Phone: 440-357-2770 |
Nancy L Albanese, CNP Pediatrics Medicare: Medicare Enrolled Practice Location: 9000 Mentor Ave Ste 100, Mentor, OH 44060 Phone: 216-383-0100 Fax: 216-383-6481 |
Laura A. Cifra-bean, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9485 Mentor Ave, #101, Mentor, OH 44060 Phone: 440-205-5800 Fax: 440-205-5801 |
Jon D Kannensohn, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9000 Mentor Ave Ste 100, Mentor, OH 44060 Phone: 440-974-4411 Fax: 440-974-4173 |
J Donald Lucker, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9485 Mentor Avenue, #101, Mentor, OH 44060 Phone: 440-205-5800 Fax: 440-205-5801 |
Robert J Magro, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9485 Mentor Ave Ste 101, Mentor, OH 44060 Phone: 440-205-5800 Fax: 440-205-5801 |
Susan M Dykeman, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9000 Mentor Ave Ste 100, Mentor, OH 44060 Phone: 216-383-0100 Fax: 216-383-6481 |
Dr. Eriks A Usis, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9000 Mentor Ave Ste 100, Mentor, OH 44060 Phone: 440-974-4470 Fax: 440-974-4173 |
News Archive
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that the Company has initiated patient dosing in a Phase II clinical trial of ACH-1625 for the treatment of hepatitis C virus (HCV) infection. ACH-1625 is a potent small molecule inhibitor of HCV protease, an enzyme necessary for viral replication. The drug candidate was discovered and is being advanced by Achillion.
In the spring of 2017, 12,146 individuals with hypothyroidism responded to an online survey posted on a variety of websites and social media for two months by the Program Committee of the Satellite Symposium on Hypothyroidism, organized by the American Thyroid Association.
Cintas Corporation, a leader in first-aid and safety products, today announced the availability of GlucoBurst, a blood sugar control product for its first-aid cabinets. According to the Centers for Disease Control and Prevention (CDC), diabetes results in 15 million missed work days and 120 million work days with reduced performance each year.
A new survey shows that despite worries about the health care law, chief financial officers anticipate improved hiring conditions over the next year, according to CBS News. Other media outlets report on Florida Sen. Marco Rubio's challenge to Health and Human Services Secretary Kathleen Sebelius to visit Seaworld where he says employees' part-time hours have been capped to avoid the requirement that they be offered health coverage.
Neuroendocrine tumors (NETs) originate from diffuse neuroendocrine cells that are dispersed throughout the body, predominantly in the gastrointestinal tract, islets of Langerhans in the pancreas and the bronchopulmonary system.
› Verified 3 days ago